Romaine Bostick reports that 2027 Medicare Advantage reimbursement rates were set at +2.5%, a "huge improvement" over the feared 0% increase floated earlier in the year. This led to a post-market surge (Humana +13%, others +9-10%). Higher government reimbursement rates directly improve the profitability outlook for managed care companies, which had seen shares decline 10-20% on fears of a rate cut. The announced rate alleviates the worst-case scenario. LONG due to a concrete positive catalyst (the rate announcement) that reverses a significant overhang on the sector and triggers immediate, substantial price appreciation. Underlying medical cost trends could still pressure earnings, and future rate decisions may be less favorable.